NCIt definition : An orally available inhibitor of maternal embryonic leucine zipper kinase (MELK) with
potential antineoplastic activity. Upon administration, OTS167 binds to MELK, which
prevents both MELK phosphorylation and activation; thus inhibiting the phosphorylation
of downstream MELK substrates. This may lead to an inhibition of both cell proliferation
and survival in MELK-expressing tumor cells. MELK, a serine/threonine kinase, is involved
in cancer cell survival, invasiveness and cancer-stem cell formation and maintenance;
it is highly upregulated in various types of cancer cells and absent in normal, healthy
cells.;
UNII : VY778IXU5T;
InChIKey : DKZYXHCYPUVGAF-JCNLHEQBSA-N;
CAS number : 1431697-89-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1431697-89-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Semantic type(s)